WebThis website is intended for adults with the polyneuropathy of hereditary transthyretin-mediated amyloidosis. TEGSEDI ® and AKCEA ® CONNECT are registered trademarks … Web16 mrt. 2024 · Ionis Pharmaceuticals, Inc. houdt zich bezig met het ontdekken en ontwikkelen van ribonucleïnezuur (RNA)-gerichte therapeutica. De onderneming richt zich voornamelijk op onze cardiovasculaire en neurologische franchises. Zijn producten omvatten SPINRAZA, TEGSEDI en WAYLIVRA.
Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals Ionis …
Web7 apr. 2024 · Ionis Pharmaceuticals announced this morning that it is pivoting from its original drug candidate for prion disease, ION716, to a new drug candidate. Ionis reaffirmed its commitment to developing a drug for prion disease, and stated a current goal of launching human trials in late 2024. Web9 dec. 2024 · 2024 Investor Day. December 9, 2024. Nasdaq: IONS. 2024 INVESTOR DAY. Participating in Today's Presentation. There will be one Q&A session at the end of today's program. Submit questions in the "Ask a Question" field and click send. A replay will be available on the Investors page of the Ionis website later today. how do you get grounded
Ionis Pharmaceuticals - Overview, News & Competitors
WebIonis is focused on delivering RNA-targeted therapeutics with transformational potential. Our antisense oligonucleotide drug discovery platform has transformed the lives of patients … WebIonis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad, CA 92010 (Carlsbad is approximately 35 miles north of downtown San Diego.) Can you provide a brief description of your Company? For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense … WebRequisition Number: IONIS003180 Schedule: Full Time 2855 Gazelle Ct HQ USA Carlsbad, CA 92010, USA We are seeking a highly qualified and motivated individual to develop novel methods to deliver therapeutic RNAs to specific cells and tissues using virus-like particles as a postdoctoral fellow. phoenix to yuma drive